# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-26-013552
Filing Date
2026-03-03
Accepted
2026-03-03 07:03:05
Documents
40
Period of Report
2026-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | espr-20260302.htm iXBRL | 8-K | 39704
2 | EX-2.1 | exhibit21.htm | EX-2.1 | 1103830
3 | EX-99.1 | a991pressrelease.htm | EX-99.1 | 26525
4 | EX-99.2 | a992investorpresentation.htm | EX-99.2 | 7840
8 |  | esperiontherapeuticsstrate.jpg | GRAPHIC | 245100
9 |  | esperiontherapeuticsstratea.jpg | GRAPHIC | 242791
10 |  | esperiontherapeuticsstrateb.jpg | GRAPHIC | 227477
11 |  | esperiontherapeuticsstratec.jpg | GRAPHIC | 301833
12 |  | esperiontherapeuticsstrated.jpg | GRAPHIC | 266772
13 |  | esperiontherapeuticsstratee.jpg | GRAPHIC | 95683
14 |  | esperiontherapeuticsstratef.jpg | GRAPHIC | 202371
15 |  | esperiontherapeuticsstrateg.jpg | GRAPHIC | 87581
16 |  | esperiontherapeuticsstrateh.jpg | GRAPHIC | 272961
17 |  | esperiontherapeuticsstratei.jpg | GRAPHIC | 243620
18 |  | esperiontherapeuticsstratej.jpg | GRAPHIC | 100221
19 |  | esperiontherapeuticsstratek.jpg | GRAPHIC | 309538
20 |  | esperiontherapeuticsstratel.jpg | GRAPHIC | 213639
21 |  | esperiontherapeuticsstratem.jpg | GRAPHIC | 476053
22 |  | esperiontherapeuticsstraten.jpg | GRAPHIC | 195514
23 |  | esperiontherapeuticsstrateo.jpg | GRAPHIC | 281533
24 |  | esperiontherapeuticsstratep.jpg | GRAPHIC | 414316
25 |  | esperiontherapeuticsstrateq.jpg | GRAPHIC | 251559
26 |  | esperiontherapeuticsstrater.jpg | GRAPHIC | 99745
27 |  | esperiontherapeuticsstrates.jpg | GRAPHIC | 264074
28 |  | esperiontherapeuticsstratet.jpg | GRAPHIC | 382831
29 |  | esperiontherapeuticsstrateu.jpg | GRAPHIC | 283309
30 |  | esperiontherapeuticsstratev.jpg | GRAPHIC | 241349
31 |  | esperiontherapeuticsstratew.jpg | GRAPHIC | 316921
32 |  | esperiontherapeuticsstratex.jpg | GRAPHIC | 314606
| Complete submission text file | 0001628280-26-013552.txt |  | 10224869

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | espr-20260302.xsd | EX-101.SCH | 1798
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | espr-20260302_lab.xml | EX-101.LAB | 22548
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | espr-20260302_pre.xml | EX-101.PRE | 13060
42 | EXTRACTED XBRL INSTANCE DOCUMENT | espr-20260302_htm.xml | XML | 2835

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 26711002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)